afp peptides
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 1999 (NCT00005629)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Alpha-fetoglobulinImmunity, active
AFP immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- afp peptides
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00669136 | Phase 1 | Jun 1, 2009 | National Cancer Institute (NCI), University of Pittsburgh |
| NCT00022334 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2001 | National Cancer Institute (NCI), University of California, Los Angeles |
| NCT00005629 | Phase 1/Phase 2 (Phase 2) | Jul 1, 1999 | National Cancer Institute (NCI), National Institutes of Health (NIH), University of California, Los Angeles |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 3 | 0 | 2 | 1999 |
| University of California, Los Angeles | Academic/Hospital | 2 | 2 | 1 | 1999 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 1999 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2009 |
4 organizations
Page 1 / 1